Print this page
-
Comparing post-test genetic counseling with and without pre-test counseling: The evolving landscape for optimizing cancer care
Protocol: 002417Principal Investigator:
- Kathryn Greene
Applicable Disease Sites: Any Site -
Therapy and Outcome Prediction using Urothelial Carcinoma orgANoids (TOUCAN).
Protocol: 002425Principal Investigator:
- Vignesh Packiam
Applicable Disease Sites: Urinary Bladder -
Research on the Epidemiology of Prostate Cancer and Environmental Levels (REPEL)
Protocol: 002438Principal Investigator:
- Hari Iyer
Applicable Disease Sites: Prostate -
Quality of Life Outcomes of Transurethral Resection of Bladder Tumor and Intravesical Therapy in Non-Muscle Invasive Bladder Cancer
Protocol: 002450Principal Investigator:
- Vignesh Packiam
Applicable Disease Sites: Urinary Bladder -
A Multi-Center Pilot Biomarker Study with Cardiopulmonary Monitoring in Lung
Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy
Protocol: 002524Principal Investigator:
- Salma Jabbour
Applicable Disease Sites: Lung -
Reducing Urban Cervical Cancer Disparities Using a Tailored mHealth Intervention to Enhance Colposcopy Attendance.
Protocol: 002351Principal Investigator:
- Shawna Hudson
Applicable Disease Sites: Cervix -
Educational Video as a Method to Improve African American Clinical Trial Enrollment.
Protocol: 002401Principal Investigator:
- Salma Jabbour
Applicable Disease Sites: Any Site -
Evaluating, Preparing, and Responding to Care Disruptions and Health Outcomes Among Patients with Breast Cancer Following Severe Storms
Protocol: 002405Applicable Disease Sites: Breast
-
Clinical Use of OptoScope: Using Vibrational Optical Coherence Tomography to
Diagnose Skin Cancer
Protocol: 002415Principal Investigator:
- Frederick Silver
Applicable Disease Sites: Melanoma, Skin -
Comparing post-test genetic counseling with and without pre-test counseling: The evolving landscape for optimizing cancer care
Protocol: 002417Principal Investigator:
- Kathryn Greene
Applicable Disease Sites: Any Site -
Therapy and Outcome Prediction using Urothelial Carcinoma orgANoids (TOUCAN).
Protocol: 002425Principal Investigator:
- Vignesh Packiam
Applicable Disease Sites: Urinary Bladder -
Research on the Epidemiology of Prostate Cancer and Environmental Levels (REPEL)
Protocol: 002438Principal Investigator:
- Hari Iyer
Applicable Disease Sites: Prostate -
Quality of Life Outcomes of Transurethral Resection of Bladder Tumor and Intravesical Therapy in Non-Muscle Invasive Bladder Cancer
Protocol: 002450Principal Investigator:
- Vignesh Packiam
Applicable Disease Sites: Urinary Bladder -
A Multi-Center Pilot Biomarker Study with Cardiopulmonary Monitoring in Lung
Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy
Protocol: 002524Principal Investigator:
- Salma Jabbour
Applicable Disease Sites: Lung -
A survey of pediatric and adolescent and young adult (AYA) cancer patients primary care providers (PCPs) regarding communication with the oncology team
Protocol: 002549Principal Investigator:
- Dawn Tortajada
Applicable Disease Sites: Any Site -
Wholeness in Healing: Evaluating the Effect of Quality of Life (QOL) on Integrative Therapy Interventions Performed During Outpatient Systemic Therapy Treatment for Women with Stage IIII Breast Cancer- A Pilot Study.
Protocol: 002553Applicable Disease Sites: Breast